Alkhatib Ghalib, Berger Edward A
Department of Microbiology and Immunology, Medical Sciences Building, Room 420, 635 Barnhill Drive. Indianapolis, IN 46202, USA.
Eur J Med Res. 2007 Oct 15;12(9):375-84.
Just over a decade ago, the specific chemokine receptors CXCR4 and CCR5 were identified as the essential coreceptors that function along with CD4 to enable human immunodeficiency virus (HIV) entry into target cells. The coreceptor discoveries immediately provided a molecular explanation for the distinct tropisms of different HIV-1 isolates for different CD4-positive target cell types, and revealed fundamentally new insights into host and viral factors influencing HIV transmission and disease. The sequential 2-step mechanism by which the HIV envelope glycoprotein (Env) interacts first with CD4, then with coreceptor, revealed a major mechanism by which conserved Env epitopes are protected from antibody-mediated neutralization. The Env-coreceptor interaction has become a major target for the development of novel antiviral strategies to treat and prevent HIV infection.
就在十多年前,特定的趋化因子受体CXCR4和CCR5被确定为与CD4协同作用以使人类免疫缺陷病毒(HIV)进入靶细胞的必需共受体。共受体的发现立即为不同HIV-1分离株对不同CD4阳性靶细胞类型的不同嗜性提供了分子解释,并揭示了影响HIV传播和疾病的宿主及病毒因素的全新见解。HIV包膜糖蛋白(Env)首先与CD4相互作用,然后与共受体相互作用的连续两步机制,揭示了保守的Env表位免受抗体介导的中和作用的主要机制。Env-共受体相互作用已成为开发治疗和预防HIV感染的新型抗病毒策略的主要靶点。